Back
Ensysce Biosciences, Inc. 10K Form
Sell
33
ENSC
Ensysce Biosciences, Inc.
Last Price:
$1.66
Seasonality Move:
22.18%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive ENSC News And Ratings
See the #1 stock for the next 7 days that we like better than ENSC
ENSC Financial Statistics
Sales & Book Value
| Annual Sales: | $5.2M |
|---|---|
| Cash Flow: | $-2M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.38 |
| Price / Book: | 4.83 |
Profitability
| EPS (TTM): | -6.09690 |
|---|---|
| Net Income (TTM): | $-11M |
| Gross Margin: | $0 |
| Return on Equity: | -330.2% |
| Return on Assets: | -193.54% |
Ensysce Biosciences, Inc. Earnings Forecast
Key Ensysce Biosciences, Inc. Financial Ratios
-
The Gross Profit Margin over the past 8 years for ENSC is 0.00%.
-
The Selling, General & Administrative Expenses for ENSC have been equal to 90.61% of Gross Profit Margin.
-
The Research & Development expenses have been 138.57% of Revenue.
-
The Net Earning history of ENSC is -153.30% of Total Revenues.
-
Per Share Earnings over the last 8 years have been positive in 4 years.
Ensysce Biosciences, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | ENSC |
| Website: | ensysce.com |
Debt
| Debt-to-Equity Ratio: | 0.3 |
|---|---|
| Current Ratio: | 1.27 |
| Quick Ratio: | 0.73 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
ENSC Technical Analysis vs Fundamental Analysis
Sell
33
Ensysce Biosciences, Inc. (ENSC)
is a Sell
Is Ensysce Biosciences, Inc. a Buy or a Sell?
-
Ensysce Biosciences, Inc. stock is rated a SellThe current Ensysce Biosciences, Inc. [ENSC] share price is $1.64. The Score for ENSC is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.